Innovative Technology AUM LifeTech's focus on next-generation RNA silencing technologies such as FANA provides a strong foundation for tailored solutions in biomedical research, therapeutic development, and agricultural pest management, creating opportunities for specialized biotech product collaborations.

Growing Funding With recent financial backing from a $400K NIH Small Business Innovation Research grant and strategic partnerships, AUM LifeTech is expanding its R&D capabilities, presenting sales prospects for innovative tools and research services in both biotech and academic sectors.

Strategic Partnerships Collaborations with Colorado State University, Boston Children’s Hospital, and USDA indicate substantial engagement with research institutions and government agencies, opening avenues for joint projects, licensing, and B2B sales of proprietary RNA silencing solutions.

Market Expansion AUM LifeTech’s diversified application scope across biomedical, agriculture, and aquaculture markets positions it as a versatile partner, suggesting potential sales opportunities for research reagents, genetic tools, and pest/disease control products tailored to broad industry needs.

Emerging Growth As a small company with a sales range up to 1 million dollars and a specialized focus, AUM LifeTech offers high-value, niche products, making it an attractive target for customized sales approaches, pilot programs, and strategic account development in the biotech research community.